Viewing nowElkatan Tablets (L-Carnitine)
L-Carnitine 330mg
Tablet · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.

MFDS item code 200810766 · Notified 2008.10.31
Treatment of carnitine deficiency and myocardial metabolic disorders due to ischemic heart disease
This medication is used to treat primary and secondary carnitine deficiency. It is also effectively used for metabolic disorders of the heart due to ischemic heart disease, such as angina and acute myocardial infarction. Overall, it helps improve metabolic issues related to heart diseases.
Adults: Administer (take) 2~3g of L-carnitine orally per day in 2~3 divided doses. Adjust the dose as appropriate according to age and symptoms.
This medication should not be used in patients with specific allergic reactions. Particularly, those who have hypersensitivity to this medication or are allergic to soybean oil, soy, or peanuts should avoid taking it. Patients with lipid metabolism issues such as hyperlipoproteinemia, diabetic dyslipidemia, or pancreatitis should use this medication with caution, as it contains fat components that could worsen their condition. After administration, gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and diarrhea, as well as changes in body odor, may occur. Allergic reactions such as skin rashes, hives, and facial swelling have also been reported. In patients with impaired kidney function, symptoms of muscle weakness may appear, so caution is needed. For patients at risk of lipid overload, it is advisable to regularly check blood lipid levels. If lipid levels are high, the dosage of this medication should be adjusted. Additionally, when using other injectables that contain fat components, it is necessary to reduce the dosage considering the fat content. Pregnant women or women of childbearing age should only use this medication when the benefits of treatment outweigh the risks, as its safety has not been sufficiently established. Nursing mothers should also use this medication cautiously, as it may be transmitted through breast milk.
Not everyone experiences these, and they can vary from person to person.
This medication should be discussed with a physician or pharmacist when used in conjunction with intravenous lipids.
This medication can be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer period.
White round film-coated tablet
90 tablets (10 tablets/PTP x 9)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowL-Carnitine 330mg
Tablet · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
L-Carnitine 200mg
Prescription medication
Albozen Korea Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Seoul Pharmaceutical Co., Ltd.
L-Carnitine 330mg
Tablet · OTC medication
HLB Pharmaceuticals Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Daehan New Pharm Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
SS Pharm Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Mothers Pharmaceuticals Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Hubist Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.